Project no.: HIV-NAT 192/HCV (NCT01838772)
This is an open-label study of standard HCV therapy with Pegylated-interferon and Ribavirin in HCV-HIV co-infected patients in routine care services in Asia to assess the effectiveness and tolerability of the treatment.
To develop a pilot model of care for treatment of HCV in RLS that is replicable and amenable to scaled implementation.